Premium Information is available for this item - Upgrade for $1 a day

6505-01-548-3881

Recombinant Antihemophilic Factor

6505015483881 015483881 NDC 000260037220 KOGENATE FS 250 IU

INC: 50876 Recombinant Antihemophilic Factor

6505-01-548-3881 ANTIHEMOPHILIC FACTOR,RECOMBINANT 6505015483881 015483881

Managed by United States
NSN Created on 21 Feb 2007
Data Last Changed
January 2023
NATO Update Count
1
NATO Data Quality
6505-01-548-3881 ANTIHEMOPHILIC FACTOR,RECOMBINANT 6505015483881 015483881 1/1
NSN 6505-01-548-3881 (Generic Image) 1/1

6505-01-548-3881 Stock and Availability Marketplace 6505-01-548-3881

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-548-3881 RQST NE eBay
eBay Updated Every Day
6505-01-548-3881 RQST eBay
Amazon Updated Every Day
6505-01-548-3881 RQST NE Amazon

6505-01-548-3881 Related Documents Related Documents 6505-01-548-3881 5+ Documents (More...)

NDC 000260037220 KOGENATE FS 250 IU Managed by United States NSN Created on 21 Feb 2007 Data Last Changed
6505-01-548-3881 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-3881
Recombinant Antihemophilic Factor 015483881 us 6505-01-548-3881 /fsg-65/fsc-6505/us 6505-01 https
Factor 015483884 fsg-65/fsc-6505/be 6505-13-120-3790 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-3881
Recombinant Antihemophilic Factor 015483881 6505-01-548-3881 /fsg-65/fsc-6505/us 6505-01 https
Factor 131203790 10ML 1182781B02BD02 Managed by Belgium NSN Created Recombinant Antihemophilic Factor 015483881
Recombinant Antihemophilic Factor 015483881 fsg-65/fsc-6505/be 6505-13-120-6409 Recombinant Antihemophilic
65/fsc-6505/us 6505-01-548-3886 Recombinant Antihemophilic Factor 015483886 Antihemophilic Factor 015483881
Antihemophilic Factor www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-3881 Recombinant Antihemophilic
10ML 1182799B02BD02 Managed by Belgium NSN Created https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-3881
Recombinant Antihemophilic Factor 015483881 3790 Recombinant Antihemophilic Factor 015483881 https
1182799B02BD02 Managed by Belgium NSN Created 120-3790 6505-99-481-9846 6505-01-548-3884 6505-01-548-3886 6505-01-548-3881
ADPEC : 3750-15-186-3751 is a Marmitta Fs 250 https https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-548-3881
Recombinant Antihemophilic Factor 015483881 6505-01-548-3881Recombinant Antihemophilic Factor6505015483881
015483881 NDC 000260037220 KOGENATE FS 250 fsc-6505/us 6505-01-548-3881 Recombinant Antihemophilic Factor

6505-01-548-3881 Demil Restrictions 6505-01-548-3881

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: A | EDC: A | ADPEC: 0

6505-01-548-3881 is a Recombinant Antihemophilic Factor that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.

6505-01-548-3881 HTS and ScheduleB Import and Export 6505-01-548-3881

6505-01-548-3881 End Users End Users 6505-01-548-3881

Turkey (ZW01)
Effective Date:
1 Feb 2007

6505-01-548-3881 Manufacturers Approved Sources 6505-01-548-3881

6505-01-548-3881 Technical Data Datasheet 6505-01-548-3881

Characteristic
Specifications
FIIG
T088-D
Special Features [FEAT]
250 Iu

6505-01-548-3881 Similar Items Similar Supply Items to 6505-01-548-3881

6505-01-548-3881 Freight Data Freight Information 6505-01-548-3881

6505-01-548-3881 has freight characteristics managed by Turkey.. 6505-01-548-3881 has a variance between NMFC and UFC when transported by rail and the description should be consulted.